757 related articles for article (PubMed ID: 11129224)
21. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
22. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
23. TT virus infection in healthy children, children after blood transfusion, and children with non-A to E hepatitis or other liver diseases in Taiwan.
Hsu HY; Ni YH; Chen HL; Kao JH; Chang MH
J Med Virol; 2003 Jan; 69(1):66-71. PubMed ID: 12436479
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
[TBL] [Abstract][Full Text] [Related]
25. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.
Kawanaka M; Niiyama G; Mahmood S; Ifukube S; Yoshida N; Onishi H; Hanano S; Ito T; Yamada G
Liver; 2002 Aug; 22(4):351-5. PubMed ID: 12296969
[TBL] [Abstract][Full Text] [Related]
26. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-transmitted virus co-infection in other types of hepatitis and its genotypes.
Zhao SS; Zhao JF; Gao CM; Wang SM
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):90-3. PubMed ID: 14607655
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt.
Gad A; Tanaka E; Orii K; Kafumi T; Serwah AE; El-Sherif A; Nooman Z; Kiyosawa K
J Med Virol; 2000 Feb; 60(2):177-81. PubMed ID: 10596018
[TBL] [Abstract][Full Text] [Related]
29. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
33. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
34. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
[TBL] [Abstract][Full Text] [Related]
35. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
36. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
37. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Watanabe H; Shinzawa H; Shao L; Saito T; Takahashi T
J Med Virol; 1999 Jul; 58(3):235-8. PubMed ID: 10447418
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
Larghi A; Tagger A; Crosignani A; Ribero ML; Bruno S; Portera G; Battezzati PM; Maggioni M; Fasola M; Zuin M; Podda M
J Med Virol; 1998 May; 55(1):7-11. PubMed ID: 9580879
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients.
López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V
J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045
[TBL] [Abstract][Full Text] [Related]
40. TTV infection in children born to mothers infected with TTV but not with HBV, HCV, or HIV.
Komatsu H; Inui A; Sogo T; Kuroda K; Tanaka T; Fujisawa T
J Med Virol; 2004 Nov; 74(3):499-506. PubMed ID: 15368510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
